463 GENES FOUND

? »

Limit search: Premium | Premium (Tissue) | Premium (Subcell) | Premium (Cell line)

« prev | Page of 10 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CA3Carbonic anhydrase III, muscle specificEnzymes
FDA approved drug targets
Plasma proteins
Tissue enriched
CA4Carbonic anhydrase IVDisease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CA7Carbonic anhydrase VIIEnzymes
FDA approved drug targets
Tissue enhanced
CACNA1ACalcium channel, voltage-dependent, P/Q type, alpha 1A subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
CACNA1BCalcium channel, voltage-dependent, N type, alpha 1B subunitFDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Group enriched
CACNA1CCalcium channel, voltage-dependent, L type, alpha 1C subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
CACNA1DCalcium channel, voltage-dependent, L type, alpha 1D subunitCancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Mixed
CACNA1GCalcium channel, voltage-dependent, T type, alpha 1G subunitFDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
CACNA1HCalcium channel, voltage-dependent, T type, alpha 1H subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
CACNA1SCalcium channel, voltage-dependent, L type, alpha 1S subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
CACNA2D1Calcium channel, voltage-dependent, alpha 2/delta subunit 1FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Mixed
CACNA2D2Calcium channel, voltage-dependent, alpha 2/delta subunit 2FDA approved drug targets
Transporters
Tissue enriched
CACNB1Calcium channel, voltage-dependent, beta 1 subunitFDA approved drug targets
Tissue enriched
CACNB2Calcium channel, voltage-dependent, beta 2 subunitDisease related genes
FDA approved drug targets
Transporters
Mixed
CACNB4Calcium channel, voltage-dependent, beta 4 subunitDisease related genes
FDA approved drug targets
Plasma proteins
Transporters
Tissue enhanced
CACNG1Calcium channel, voltage-dependent, gamma subunit 1FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
CALYCalcyon neuron-specific vesicular proteinFDA approved drug targets
Predicted membrane proteins
Group enriched
CAMLGCalcium modulating ligandFDA approved drug targets
Predicted membrane proteins
Transporters
Expressed in all
CARTPTCART prepropeptideFDA approved drug targets
Predicted secreted proteins
Tissue enriched
CASRCalcium-sensing receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enhanced
CATCatalaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
CCKARCholecystokinin A receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
CCKBRCholecystokinin B receptorCancer-related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
CCL2Chemokine (C-C motif) ligand 2Cancer-related genes
Candidate cardiovascular disease genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Expressed in all
CCND1Cyclin D1Cancer-related genes
Disease related genes
FDA approved drug targets
Mixed
CD44CD44 molecule (Indian blood group)Blood group antigen proteins
Cancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
CES1Carboxylesterase 1Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Group enriched
CFTRCystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Group enriched
CHD1Chromodomain helicase DNA binding protein 1Enzymes
FDA approved drug targets
Expressed in all
CHRM1Cholinergic receptor, muscarinic 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
CHRM2Cholinergic receptor, muscarinic 2Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
CHRM3Cholinergic receptor, muscarinic 3Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
CHRM4Cholinergic receptor, muscarinic 4FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
CHRM5Cholinergic receptor, muscarinic 5FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
CHRNA10Cholinergic receptor, nicotinic, alpha 10 (neuronal)FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
CHRNA3Cholinergic receptor, nicotinic, alpha 3 (neuronal)FDA approved drug targets
Predicted membrane proteins
Tissue enriched
CHRNA4Cholinergic receptor, nicotinic, alpha 4 (neuronal)Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enhanced
CHRNA7Cholinergic receptor, nicotinic, alpha 7 (neuronal)FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Mixed
CHRNB2Cholinergic receptor, nicotinic, beta 2 (neuronal)Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
CKBCreatine kinase, brainCancer-related genes
Candidate cardiovascular disease genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
CKMCreatine kinase, muscleCandidate cardiovascular disease genes
Enzymes
FDA approved drug targets
Plasma proteins
Tissue enriched
CKMT1ACreatine kinase, mitochondrial 1AEnzymes
FDA approved drug targets
Mitochondrial proteins
Predicted secreted proteins
Mixed
CKMT1BCreatine kinase, mitochondrial 1BEnzymes
FDA approved drug targets
Mitochondrial proteins
Predicted secreted proteins
Mixed
CKMT2Creatine kinase, mitochondrial 2 (sarcomeric)Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Group enriched
CLCN2Chloride channel, voltage-sensitive 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Mixed
CNR1Cannabinoid receptor 1 (brain)FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
CNR2Cannabinoid receptor 2 (macrophage)FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
COMTCatechol-O-methyltransferaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Expressed in all
CPS1Carbamoyl-phosphate synthase 1, mitochondrialDisease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Group enriched
CPT1ACarnitine palmitoyltransferase 1A (liver)Disease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Predicted membrane proteins
Expressed in all

« prev | Page of 10 | next »